NeoTherma Oncology
About:
NeoTherma Oncology is a Bioelectric device developer.
Website: http://www.neothermaoncology.com/
Top Investors: R & K Edwards Investments, Gary Barnett, Flor-Med Partners
Description:
NeoTherma Oncology is developing VectRx™, a noninvasive thermal oncology therapeutic device system for treatment of a wide range of cancers in addition to Pancreatic Ductal Adenocarcinoma, the eighth most common cancer but the fourth leading cause of cancer death in the United States. VectRx is designed to ‘plug and play’ with the global installed base of MRI scanners to deliver non-invasive, image-guided adjuvant thermal oncology therapy, which is expected to increase life expectancy and improve quality of life of patients who receive it in addition to standard-of-care radio-, chemo- and immuno- therapies.
$6M
$1M to $10M
Wichita, Kansas, United States
2015-01-01
John Kanzius
1-10
2018-08-20
Private
© 2025 bioDAO.ai